PRO1107 in Patients With Advanced Solid Tumors

Conditions: Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial Carcinoma Interventions: Drug: PRO1107 Sponsors: ProfoundBio US Co. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials